BioGeometry
PrivateLast Round
Series A
Jun 8, 2026
Total Funding Raised
$10M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
BioGeometry is a biotechnology company that develops an AI-driven platform for programmable protein design and drug discovery.
Sector
Consumer & Commerce
Verticals
Home & Lifestyle, D2C Brands
Business Model
B2C
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioGeometry Comparables
Compare BioGeometry with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alphabet Inc. | 71% | |
| Tencent | 70% | |
| ByteDance | 63% |
BioGeometry Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 8, 2026 | ||||
| Pre Seed | Jun 18, 2024 | ||||
| Angel | Sep 21, 2022 |
BioGeometry Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Link-X Capital | Series A |
| China Science and Technology Industry Investment Management | Series A |
| Shengjing Jiacheng | Pre Seed |
| Shenzhen Dachen Caizhi Venture Capital Management | Series A |
| Gaorong Capital | Angel, Series A, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors increased 33% MoM, reaching 2.5K.
- Jun 8, 2026
Led by China Science and Technology Industry Investment Management, Link-X Capital, and Shenzhen Dachen Caizhi.
BioGeometry Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BioGeometry's valuation, stock price, and market status.
Is BioGeometry a public or private company?
BioGeometry is a private company.
What is the current stock price of BioGeometry?
BioGeometry is a private company with no public stock price. No recent secondary market data is available.
How much is BioGeometry worth (valuation)?
Valuation information for BioGeometry is not publicly available.
Can I buy BioGeometry stock?
BioGeometry shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BioGeometry's last funding round?
BioGeometry's most recent funding round was Series A on June 8, 2026.
Who are the main investors in BioGeometry?
Key investors in BioGeometry include Link-X Capital, China Science and Technology Industry Investment Management, Shenzhen Dachen Caizhi Venture Capital Management.
Will BioGeometry IPO soon?
No public IPO plans have been announced for BioGeometry.
How can I track BioGeometry secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BioGeometry's secondary market activity and sign up for updates.